Kangrong Pharmaceutical’s Memantine Hydrochloride Oral Solution Approved

Anhui Kangrong Pharmaceutical Co., Ltd.’s Memantine Hydrochloride Oral Solution has recently received regulatory approval, with the drug approval number NMPA Approval No. H20256289. The product is available in a strength of 120 mL: 0.24 g.

Memantine Hydrochloride Oral Solution is clinically indicated for the treatment of moderate to severe Alzheimer’s dementia. Its mechanism of action primarily involves antagonism of NMDA receptors, helping to reduce neuronal damage and improve cognitive function.